Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany

Abstract To investigate the associations of leptin, adiponectin and high-sensitive (hs) C-reactive protein (CRP) with risk and prognosis of amyotrophic lateral sclerosis (ALS). Data from a population-based case-control study in Southern Germany (10/2010–6/2014) of 289 ALS patients (mean age of 65.7...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gabriele Nagel, Raphael S. Peter, Angela Rosenbohm, Wolfgang Koenig, Luc Dupuis, Dietrich Rothenbacher, Albert C. Ludolph
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8d66d0c8914b4668a9930c9e57470215
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8d66d0c8914b4668a9930c9e57470215
record_format dspace
spelling oai:doaj.org-article:8d66d0c8914b4668a9930c9e574702152021-12-02T11:40:52ZAdipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany10.1038/s41598-017-04706-52045-2322https://doaj.org/article/8d66d0c8914b4668a9930c9e574702152017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04706-5https://doaj.org/toc/2045-2322Abstract To investigate the associations of leptin, adiponectin and high-sensitive (hs) C-reactive protein (CRP) with risk and prognosis of amyotrophic lateral sclerosis (ALS). Data from a population-based case-control study in Southern Germany (10/2010–6/2014) of 289 ALS patients (mean age of 65.7 (SD 10.5) years, 59.5% men) and 506 controls were included. During median follow-up of 14.5 months of 279 ALS patients 104 (53.9% men, 68.9 (10.3) years) died. Serum samples were measured for leptin, adiponectin and hs-CRP. Conditional logistic regression was used to estimate ALS risk. Survival models were used to appraise the prognostic value. ALS patients were characterized by lower levels of school education, BMI and smoking prevalence. Adjusted for covariates, leptin was inversely associated with ALS risk (top vs. bottom quartile: OR 0.49; 95% CI 0.29–0.80), while for adiponectin a positive association was found (OR 2.89; 95% CI 1.78–4.68). Among ALS patients increasing leptin concentrations were associated with longer survival (p for trend 0.002), while for adiponectin no association was found (p for trend 0.55). For hs-CRP no association was found. Leptin and adiponectin, two key hormones regulating energy metabolism, were strongly and independently related with ALS risk. Leptin levels were further negatively related with overall survival of ALS patients.Gabriele NagelRaphael S. PeterAngela RosenbohmWolfgang KoenigLuc DupuisDietrich RothenbacherAlbert C. LudolphNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Gabriele Nagel
Raphael S. Peter
Angela Rosenbohm
Wolfgang Koenig
Luc Dupuis
Dietrich Rothenbacher
Albert C. Ludolph
Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany
description Abstract To investigate the associations of leptin, adiponectin and high-sensitive (hs) C-reactive protein (CRP) with risk and prognosis of amyotrophic lateral sclerosis (ALS). Data from a population-based case-control study in Southern Germany (10/2010–6/2014) of 289 ALS patients (mean age of 65.7 (SD 10.5) years, 59.5% men) and 506 controls were included. During median follow-up of 14.5 months of 279 ALS patients 104 (53.9% men, 68.9 (10.3) years) died. Serum samples were measured for leptin, adiponectin and hs-CRP. Conditional logistic regression was used to estimate ALS risk. Survival models were used to appraise the prognostic value. ALS patients were characterized by lower levels of school education, BMI and smoking prevalence. Adjusted for covariates, leptin was inversely associated with ALS risk (top vs. bottom quartile: OR 0.49; 95% CI 0.29–0.80), while for adiponectin a positive association was found (OR 2.89; 95% CI 1.78–4.68). Among ALS patients increasing leptin concentrations were associated with longer survival (p for trend 0.002), while for adiponectin no association was found (p for trend 0.55). For hs-CRP no association was found. Leptin and adiponectin, two key hormones regulating energy metabolism, were strongly and independently related with ALS risk. Leptin levels were further negatively related with overall survival of ALS patients.
format article
author Gabriele Nagel
Raphael S. Peter
Angela Rosenbohm
Wolfgang Koenig
Luc Dupuis
Dietrich Rothenbacher
Albert C. Ludolph
author_facet Gabriele Nagel
Raphael S. Peter
Angela Rosenbohm
Wolfgang Koenig
Luc Dupuis
Dietrich Rothenbacher
Albert C. Ludolph
author_sort Gabriele Nagel
title Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany
title_short Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany
title_full Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany
title_fullStr Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany
title_full_unstemmed Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany
title_sort adipokines, c-reactive protein and amyotrophic lateral sclerosis – results from a population- based als registry in germany
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/8d66d0c8914b4668a9930c9e57470215
work_keys_str_mv AT gabrielenagel adipokinescreactiveproteinandamyotrophiclateralsclerosisresultsfromapopulationbasedalsregistryingermany
AT raphaelspeter adipokinescreactiveproteinandamyotrophiclateralsclerosisresultsfromapopulationbasedalsregistryingermany
AT angelarosenbohm adipokinescreactiveproteinandamyotrophiclateralsclerosisresultsfromapopulationbasedalsregistryingermany
AT wolfgangkoenig adipokinescreactiveproteinandamyotrophiclateralsclerosisresultsfromapopulationbasedalsregistryingermany
AT lucdupuis adipokinescreactiveproteinandamyotrophiclateralsclerosisresultsfromapopulationbasedalsregistryingermany
AT dietrichrothenbacher adipokinescreactiveproteinandamyotrophiclateralsclerosisresultsfromapopulationbasedalsregistryingermany
AT albertcludolph adipokinescreactiveproteinandamyotrophiclateralsclerosisresultsfromapopulationbasedalsregistryingermany
_version_ 1718395528895528960